Carepool
Carepool is developing an app that streamlines the search, planning, and administration of care for persons on a personal budget.
Carepool is developing an app that streamlines the search, planning, and administration of care for persons on a personal budget.
Carepool has raised $350k across 1 round. Its most recent round was a Seed of $350k in Sep 2025. Full funding history, investors, and team are detailed below.
Funding history
1 round on record.
Unlock the lead investor and full details for this round.
People
Founders, executives, and decision-makers — sourced and refreshed weekly.
See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.
Carepool is featured in
Similar companies
Juisci SaaS model reinvents the way healthcare professionals interact with evidence-based content.
The UK's first health regulated dental app. Using AI award winning tech patients can access emergencies, prescriptions and cosmetics in app.
Lōvu Health is a digital maternal health platform that offers services to care for mother and baby from conception to postpartum.
Penguin AI uses AI to analyze health records and support care decisions, improving patient outcomes.
ProQR Therapeutics is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa. The company's main product candidates are QR-010, QR-110, and QR-313. Its product pipeline includes QRX-704, QRX-504, QRX-421, QRX-323 etc.
uniQure is a leader in the field of gene therapy and had developed the first and currently the only gene therapy product to receive regulatory approval in the European Union. Gene therapy offers the prospect of long-term and potentially curative benefit to patients with genetic or acquired diseases by directing the expression of a therapeutic protein or restoring the expression of a missing protein through a single administration. Our first product, Glybera, was approved by the European Commission in October 2012 under exceptional circumstances for the treatment of a subset of patients with lipoprotein lipase deficiency, or LPLD, a potentially life-threatening, orphan metabolic disease. We are also developing a pipeline of additional adeno-associated virus (AAV)-based gene therapies through multiple collaborations. We develop our gene therapies using our innovative, modular technology platform, including our proprietary manufacturing process. We initially are focused on orphan diseases but believe that we will also be able to develop gene therapies targeting chronic and degenerative diseases that affect larger populations.
Droppie is a recycling company that makes recycling easy and more accessible for consumers. The app is designed to help consumers recycle more effectively by offering small rewards for their recycled materials.
Schunk Xycarb Technology develops and manufactures high-tech quartz, ceramic, and graphite consumable parts utilized in semiconductor wafer processing equipment. The company provides specialized engineering and coating services to help global chipmakers optimize performance during advanced manufacturing processes.
Vertoro transforms woody and agricultural residues into a wide range of bio-based chemicals, materials, and fuels.
Vivici is a B2B ingredients firm that provides nutritious and sustainable animal-free dairy proteins manufactured with precision fermentation to food and beverage manufacturers.
OurMind is a HealthTech startup that builds generative AI tools to automate administrative and clinical workflows for healthcare professionals. Its flagship software captures real-time doctor-patient conversations across 90 languages and instantly converts them into structured medical notes. Built by medical providers and co-owned by dozens of specialists, the platform saves clinicians roughly 2 to 3 hours of paperwork daily to combat industry-wide burnout.
The trust and distribution layer for AI agents
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.